Displaying 81 - 90 of 121
Active Status: Unknown
User: Male
Mode: Yes
Delivery Type: Oral
Developer: University of Washington, GlaxoSmithKline, NICHD
Project Stage: Phase I
Active Status: No
User: Female
Mode: No
Delivery Type: Barrier
Developer: NIAID, NICHD, Origami Healthcare Products, Inc., Strata Various Product Design
Project Stage: Phase II
Active Status: Yes
User: Female
Mode: No
Delivery Type: Barrier, Vaginal Ring
Developer: Dare BioScience Inc.
Project Stage: Phase II
Active Status: Unknown
User: Female
Mode: Yes
Delivery Type: Injectable
Developer: Vel's College of Pharmacy
Project Stage: Pre-clinical
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Oral
Developer: HRA Pharma, Gynuity Health Projects, PATH
Project Stage: Phase III
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Oral
Developer: Stanford University
Project Stage: Phase I
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Injectable
Developer: Shanghai Institute of Planned Parenthood Research (SIPPR), FHI 360
Project Stage: Pre-clinical
Active Status: Unknown
User: Female
Mode: Yes
Delivery Type: Injectable
Developer: Vel's College of Pharmacy
Project Stage: Pre-clinical
Alternative Name: Polidocanol Foam Permanent Contraception
Active Status: Yes
User: Female
Mode: No
Delivery Type: Fallopian Tube
Developer: Oregon Health & Science University
Project Stage: Pre-clinical
Pages
